The deal does not include a provision to raise the debt limit. After days of heated negotiations on Capitol Hill and eleventh-hour interference from President-elect Donald Trump and his ally Elon ...

Rich Scherr is a seasoned journalist and editor who has traveled across the U.S., Canada, and Europe, and spent more than a decade reviewing hotel room.

The Biden administration announced Monday its final weapons and aid package to Ukraine before President-elect Trump is set to take the reins in Washington. The White House announced a $1.25 ...

If you’re tired of struggling with makeshift solutions to track and secure your luggage, there's a TSA-approved solution. SmartLock integrates with Apple's Find My, allowing you to track your ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some ...

The actual earphones have been approved as devices “adjusted by the user to meet their hearing needs without the assistance of a hearing professional”. “The feature is intended to amplify ...

GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea By India Edwards HealthDay Reporter MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly medicine initially developed as a treatment ...

BRUSSELS, Dec 23 (Reuters) - U.S. chip design software company Synopsys (SNPS.O), opens new tab is set to win conditional EU antitrust approval for its $35 billion buy of Ansys (ANSS.O), opens new ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...